These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 25569341)
1. Linking the VPS35 and EIF4G1 pathways in Parkinson's disease. Ross OA; Cook C; Petrucelli L Neuron; 2015 Jan; 85(1):1-3. PubMed ID: 25569341 [TBL] [Abstract][Full Text] [Related]
2. VPS35 and EIF4G1 interactions and novel candidate genes for PD: from genes to pathways and back. Erro R Mov Disord; 2015 Apr; 30(4):499. PubMed ID: 25771811 [No Abstract] [Full Text] [Related]
4. D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population. Kalinderi K; Bostantjopoulou S; Katsarou Z; Dimikiotou M; Fidani L Neurosci Lett; 2015 Oct; 606():113-6. PubMed ID: 26300542 [TBL] [Abstract][Full Text] [Related]
5. Frequency of the ASP620ASN mutation in VPS35 and Arg1205His mutation in EIF4G1 in familial Parkinson's disease from South Italy. Gagliardi M; Annesi G; Tarantino P; Nicoletti G; Quattrone A Neurobiol Aging; 2014 Oct; 35(10):2422.e1-2. PubMed ID: 24854799 [TBL] [Abstract][Full Text] [Related]
6. VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians. Sudhaman S; Behari M; Govindappa ST; Muthane UB; Juyal RC; Thelma BK Neurobiol Aging; 2013 Oct; 34(10):2442.e1-3. PubMed ID: 23726718 [TBL] [Abstract][Full Text] [Related]
7. Increased copper toxicity in Saccharomyces cerevisiae lacking VPS35, a component of the retromer and monogenic Parkinson disease gene in humans. Sowada N; Stiller B; Kubisch C Biochem Biophys Res Commun; 2016 Aug; 476(4):528-533. PubMed ID: 27262440 [TBL] [Abstract][Full Text] [Related]
8. VPS35 Asp620Asn and EIF4G1 Arg1205His mutations are rare in Parkinson disease from southwest China. Chen Y; Chen K; Song W; Chen X; Cao B; Huang R; Zhao B; Guo X; Burgunder J; Li J; Shang HF Neurobiol Aging; 2013 Jun; 34(6):1709.e7-8. PubMed ID: 23261770 [TBL] [Abstract][Full Text] [Related]
9. EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa. Blanckenberg J; Ntsapi C; Carr JA; Bardien S Neurobiol Aging; 2014 Feb; 35(2):445.e1-3. PubMed ID: 24080171 [TBL] [Abstract][Full Text] [Related]
10. Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease. Nuytemans K; Bademci G; Inchausti V; Dressen A; Kinnamon DD; Mehta A; Wang L; Züchner S; Beecham GW; Martin ER; Scott WK; Vance JM Neurology; 2013 Mar; 80(11):982-9. PubMed ID: 23408866 [TBL] [Abstract][Full Text] [Related]
12. Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration. Griffin EF; Yan X; Caldwell KA; Caldwell GA Hum Mol Genet; 2018 Dec; 27(24):4176-4193. PubMed ID: 30508205 [TBL] [Abstract][Full Text] [Related]
13. The EIF4G1 gene and Parkinson's disease. Deng H; Wu Y; Jankovic J Acta Neurol Scand; 2015 Aug; 132(2):73-8. PubMed ID: 25765080 [TBL] [Abstract][Full Text] [Related]
14. EIF4G1 mutations do not cause Parkinson's disease. Nichols N; Bras JM; Hernandez DG; Jansen IE; Lesage S; Lubbe S; Singleton AB; Neurobiol Aging; 2015 Aug; 36(8):2444.e1-4. PubMed ID: 26022768 [TBL] [Abstract][Full Text] [Related]
15. VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease. Miura E; Hasegawa T; Konno M; Suzuki M; Sugeno N; Fujikake N; Geisler S; Tabuchi M; Oshima R; Kikuchi A; Baba T; Wada K; Nagai Y; Takeda A; Aoki M Neurobiol Dis; 2014 Nov; 71():1-13. PubMed ID: 25107340 [TBL] [Abstract][Full Text] [Related]
16. High expression levels of the D686N Parkinson's disease mutation in VPS35 induces α-synuclein-dependent toxicity in yeast. Huang Y; Chen X; He X; Guo C; Sun X; Liang F; Long S; Lu X; Feng L; Guo W; Zeng Y; Pei Z Mol Med Rep; 2017 Jul; 16(1):254-262. PubMed ID: 28487947 [TBL] [Abstract][Full Text] [Related]
17. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil. Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137 [TBL] [Abstract][Full Text] [Related]
18. Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways. Khurana V; Peng J; Chung CY; Auluck PK; Fanning S; Tardiff DF; Bartels T; Koeva M; Eichhorn SW; Benyamini H; Lou Y; Nutter-Upham A; Baru V; Freyzon Y; Tuncbag N; Costanzo M; San Luis BJ; Schöndorf DC; Barrasa MI; Ehsani S; Sanjana N; Zhong Q; Gasser T; Bartel DP; Vidal M; Deleidi M; Boone C; Fraenkel E; Berger B; Lindquist S Cell Syst; 2017 Feb; 4(2):157-170.e14. PubMed ID: 28131822 [TBL] [Abstract][Full Text] [Related]
19. Mutations in EIF4G1 are not a common cause of Parkinson's disease. Siitonen A; Majounie E; Federoff M; Ding J; Majamaa K; Singleton AB Eur J Neurol; 2013 Apr; 20(4):e59. PubMed ID: 23490116 [No Abstract] [Full Text] [Related]
20. VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology. Cutillo G; Simon DK; Eleuteri S Neurobiol Dis; 2020 Nov; 145():105056. PubMed ID: 32853677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]